Our hot stock of the week, Neuren Pharmaceuticals, could soon be one of a handful of ASX-listed companies with an FDA-approved drug.
Sign up to Money Newsletter
Welcome to Money!
You'll now receive new articles and insights that will help you earn more, save more and make the most of your investments.
You can expect to hear from us every week.
In the meantime, stay up to date by following Money on social media.
Important
To ensure you receive emails from us, we recommend that you add our email address (@moneymag.com.au) to your contacts or safe senders list.
If you don't receive our newsletters, please check your "Junk" folders. Your email provider should give you an option to add the email to your safe list.
The Money team